registered by 1 EU member state are automatically recognized by other member states. The United States classifies herbs as “dietary supplements” under the Dietary Supplement Health and Education Act of 1994. This article provides information from the literature and government websites to illustrate differences in regulations for herbal medicines in China, Germany, and the United States. It also explores regulatory strategies that could be used to create more uniform worldwide policies regarding herbal medicines.

Herbal Medicine Regulation in China, Germany, and the United States

The designation `sociology of health' or `medical anthropology/sociology' indicates, at best, only the field and not the peculiarities of the field. As a consequence much work in this sub-discipline is of the genre, `Sociology/Anthropology: Case Study Illness (or Health)'. This paper attempts to regroup the contributions made in this field in order to demonstrate the utility of establishing the specificities of the sub-discipline `sociology/anthroplogy of illness'. Such an exercise would also provide us with a consistent framework for formulating health policies as well as for appreciating the reasons why WHO's blueprint of `Health for All' and China's `Barefoot Doctor' programme ran into difficulties. Furthermore, a systematic pursuit of the specificities of sociology/anthropology of illness would also force us to mutate our understanding of at least a few received formulations on the sociology/anthropology of deviance, professions, and even of tradition and modernity.

For a sociology/anthropology of illness: towards a delineation of its disciplinary specificities

~:J ~ This overview of the Chinese pharmaceutical market examines the product, promotion, and distribution advantages, as well as the price disadvantage of foreign pharmaceutical joint ventures in the People's Republic of China. Prospects for foreign investment in the Chinese health care industry are evaluated positively based on current Chinese government policies in that area.

u.s. Pharmaceutical Firm Prospects within the People's Republic of China

(1981). Struggles over health care in the Peoples' Republic of China. Journal of Contemporary Asia: Vol. 11, No. 1, pp. 91-103.

Garfield R

Papers

Struggles over health care in the People's Republic of China.